Made this post on another site. I believe it, but I also

New Post Public Reply Private Reply Replies (2) Message Board
petemantx
544
Made this post on another site. I believe it, but I also wanted to see if it would be allowed to stay up and what reaction those that I know are being paid to scuttle IPIX have to say about it. Everyone knows I post in part to get a reaction, so if you don't agree with this, so be it. I don't mind hearing how my thinking is off as long as you provide cogent reasoning as to why you feel it is wrong:

One possible reason that nobody has ventured yet is that IPIX, thru LW, is in deep negotiation talks with BPs for OM and IBD and BPs are scared to death that their multi-year plan to drive IPIX into bankruptcy is about to explode in their faces.

Major BPs have been aware of IPIX and its two active drugs, Kevetrin and Brilacidin, and their staggering potential for years.

BPs have massive amounts of money, they know how to play hardball, and they are not averse to doing whatever is necessary to secure such profitable IP at rock bottom pricing.

I believe we have a BP or two that have been part of the concerted effort against the IPIX share price (and thus its ability to raise funds at reasonable rates) to try and drive it into bankruptcy so they could buy the IP for pennies. I think the action is funded thru offshore accounts and managed in the USA. The sum wouldn't put a dent in their cash positions but it has been extremely costly for IPIX both in time and money in bringing these powerhouse drugs to market. The plan involves naked shorts, teams of paid posters on message boards, the phony lawsuit brought against the company, what I consider to be outrageous placebo cures in our clinical trials that were standard deviations outside normal expectations (not too hard to find the handful of clinical trial sites and pay a few people at each site to do what they want to make sure the trials don't come out as strong as one would expect.

Most on this board have been shaking their heads as to the disconnect between the science and the stock price and the action against the company on many forums.

Some may say too fantastical to believe, but that is why the BPs know they can get away with it. They don't worry about the SEC, FINRA, or any other regulatory agency as they are paid off as well. If they weren't, we would have T+0 trade accountability in the market instead of the T+2 which gives MMs the right to steal from retail with naked shorts.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Dell Technologies: A Fresh Look at Investor Sentiment Trends

Updated Category News Views 285

Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...

Continue Reading
Compass Diversified Faces Investigation for Securities Violations

Updated Category News Views 173

Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...

Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities

Updated Category News Views 226

Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...

Continue Reading
Growth Prospects of the Global Medical Imaging Reagents Market

Updated Category News Views 148

Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...

Continue Reading
Mike Tyson Teams Up with GBank Financial in New Venture

Updated Category News Views 285

GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...

Continue Reading